PCSK9-mediated LDL receptor degradation (Homo sapiens)

Revision as of 11:51, 8 September 2014 by Susan (Talk | contribs)

Description

No description

View approved pathways at the new wikipathways.org.

Brautbar A, Ballantyne CM; ''Pharmacological strategies for lowering LDL cholesterol: statins and beyond.''; Nat Rev Cardiol, 2011 PubMed Europe PMC Scholia

View all...

Revision	Action	Time	User	Comment
128066	view	00:05, 24 January 2024	Eweitz	A bit more mitigation of Golgi distortion in website
128065	view	00:04, 24 January 2024	Eweitz	Try further mitigating Golgi distortion in website rendering
128064	view	00:03, 24 January 2024	Eweitz	Mitigate Golgi distortion (site shows it partly extracellular, PathVisio shows it fully intracellular); upgrade "LDL particles" label to "LDL cholesterol" metabolite node
128063	view	23:55, 23 January 2024	Eweitz	Ontology Term : 'cholesterol metabolic pathway' added !
128062	view	23:52, 23 January 2024	Eweitz	Ontology Term : 'hepatocyte' added !
116729	view	10:27, 11 May 2021	Eweitz	Modified title
89409	view	20:16, 10 September 2016	AlexanderPico	Modified title
89108	view	15:11, 22 August 2016	Evelo	Modified description
89107	view	15:10, 22 August 2016	Evelo	Modified title
89106	view	15:10, 22 August 2016	Evelo	Modified title
89105	view	15:09, 22 August 2016	Evelo	Modified description
88292	view	15:00, 1 August 2016	Fehrhart	Ontology Term : 'lipoprotein metabolic pathway' added !
83009	view	09:34, 17 November 2015	Fehrhart	Updated ensembl ID for LDLR
78515	view	10:29, 7 January 2015	MaintBot	added missing graphIds
77448	view	13:36, 9 September 2014	Susan	Connect line
77430	view	11:51, 8 September 2014	Susan	Modified description
77429	view	11:50, 8 September 2014	Susan	New pathway

Name	Type	Database reference	Comment
LDLR	GeneProduct	ENSG00000270150 (Ensembl)
PCSK9	GeneProduct	ENSG00000169174 (Ensembl)

No annotated interactions